AIM
NAGE

Acrospire Investment Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Acrospire Investment Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,513
Closed -$17K – 1495
2017
Q2 		$17K Buy
4,513
+2,600
+136% +$9.79K 0.02% 1624
2017
Q1 		$5K Buy
+1,913
New +$5K ﹤0.01% 2019